|
R&D Leaders' Forum
Mikael Dolsten, MD, PhD, President, BioTherapeutics Research & Development, Pfizer Inc
Lee E. Babiss, PhD, Head of Global Pharma Research, Roche
Professor Jackie Hunter,Senior Vice President, Science Environment Development, GlaxoSmithKline
Dr Robert Booth, Operating Partner, TPG Ventures & Executive Chairman, ViroBay, Inc
Dr Christine J. Cioffe, Vice President, Strategic & Enterprise-wide Portfolio Management, Merck & Co, Inc
Hartmut J. Ehrlich, MD, Vice President, Global R&D, Baxter BioScience
Dr Nicholas Dracopoli, Vice President, Biomarkers & Translational Research, Johnson & Johnson
Dr Nahed Ahmed, Vice President, Program Management & Strategic Operations, Amgen, Inc
Wayne A. Rosenkrans, Jr, PhD, Distinguished Fellow, MIT Center for Biomedical Innovation; Program in Ethics & Systems Medicine, Georgetown University; Chairman & President, Personalized Medicine Coalition; Vice President, Strategic Consulting, Fuld and Co; Chief Applications Officer, SciTech Strategies
Dr David Hughes, Managing Director, Future Drugs Ltd
|
Oncology Leaders' Forum
Dr Richard Gaynor, Vice President, Cancer Research & Clinical Investigation, Eli Lilly and Company
Roy Baynes, MD, PhD, Vice President, Global Clinical Development & Therapeutic Area Head Hematology/Oncology, Amgen, Inc
Dr Howard Fingert, Senior Director, Clinical Development, Millennium, the Takeda Oncology Company
H. Kim Lyerly, MD, Director, Duke Comprehensive Cancer Center
Dr David Urdal, Chief Scientific Officer, Dendreon Corporation
Thomas G. Roberts, MD, MSocSci, Senior Health Care Analyst & Portfolio Manager, Noonday Asset Management, LP (sub-adviser to Farallon Capital Management, LLC)
Mike McCully, Director & Senior Analyst, Deloitte Recap LLC
Pat Stanfill Edens, RN, PhD, FACHE, FAAMA, Principal, Global Oncology Assistant Vice President, HCA, Hospital Corporation of America
|
